- Home
- WU vs SLNO Comparison
WU vs SLNO Comparison
Compare WU & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$9.35
HOLD
Current Price
$47.67
Company Overview
Basic Information| Metric | WU | SLNO |
|---|---|---|
| Founded | 1851 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.5B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WU | SLNO |
|---|---|---|
| Price | $9.35 | $47.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $8.75 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 7.8M | 1.3M |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | ★ 10.00% | N/A |
| EPS Growth | ★ 18.91 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $4,100,500,000.00 | $98,675,000.00 |
| Revenue This Year | $0.13 | N/A |
| Revenue Next Year | $0.74 | $155.86 |
| P/E Ratio | $4.06 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.85 | $41.50 |
| 52 Week High | $11.95 | $90.32 |
Technical Indicators
Market Signals| Indicator | WU | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 41.69 |
| Support Level | $9.21 | $47.01 |
| Resistance Level | $9.43 | $49.75 |
| Average True Range (ATR) | 0.19 | 2.32 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 41.49 | 7.38 |
Price Performance
Historical Comparison WU
SLNO
About WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.